Why Fentanyl Citrate In All Strengths is in shortage
regulatory action — e.g. “CGMP Deviations: Revised interpretation of Acceptable Quality Level (AQL) results.” (United States)
causes not stated by the regulator
— e.g. “Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay” (United States)
Recent shortage history
Thailand: resolved 3 Jul 2026 (began 5 Oct 2022)
Frequently asked questions
Is Fentanyl Citrate In All Strengths currently in shortage?
Yes. As of the latest regulator updates, Fentanyl Citrate In All Strengths has 4 active shortage notices across 1 country (United States). Status is refreshed daily from official regulatory sources.
Why is Fentanyl Citrate In All Strengths in shortage?
Regulators attribute the current Fentanyl Citrate In All Strengths shortages to regulatory action, causes not stated by the regulator. The exact cause varies by country and product — each notice on this page links to the official source.
Where does this Fentanyl Citrate In All Strengths shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Get alerted when Fentanyl Citrate In All Strengths status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Data on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.